Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
7.51
-0.32 (-4.09%)
At close: Apr 1, 2025, 4:00 PM
7.55
+0.04 (0.51%)
After-hours: Apr 1, 2025, 4:56 PM EDT

Avadel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
7261,013----
Upgrade
Enterprise Value
694985----
Upgrade
Last Close Price
7.8310.51----
Upgrade
Forward PE
50.96200.19----
Upgrade
PS Ratio
4.405.99----
Upgrade
PB Ratio
10.2313.71----
Upgrade
P/TBV Ratio
17.7617.76----
Upgrade
EV/Sales Ratio
4.105.83----
Upgrade
Debt / Equity Ratio
0.530.530.41-6.201.850.80
Upgrade
Asset Turnover
1.031.030.19--0.10
Upgrade
Inventory Turnover
1.001.00----
Upgrade
Quick Ratio
2.212.213.181.778.9917.30
Upgrade
Current Ratio
2.752.753.641.819.1717.44
Upgrade
Return on Equity (ROE)
-60.44%-60.44%-481.35%-481.49%-64.30%10.56%
Upgrade
Return on Assets (ROA)
-16.11%-16.11%-57.92%-31.32%-19.14%-9.90%
Upgrade
Return on Capital (ROIC)
-22.41%-22.41%-73.72%-35.73%-20.73%-11.64%
Upgrade
Earnings Yield
-6.70%-4.82%----
Upgrade
FCF Yield
-6.44%-4.63%----
Upgrade
Buyback Yield / Dilution
-18.67%-18.67%-33.41%-2.66%-6.54%-46.89%
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q